While the role of such an O-GlcNAcylation in cancer is still under investigation, the aberrant O-GlcNAcylation cycling, as well as the silencing of OGT, have been analyzed either in normal cell physiology or in other human diseases. The gene discussed is OGT; the disease is cancer.